{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:32:27Z","timestamp":1789842747794,"version":"4.0.1"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,19]]},"DOI":"10.7759\/cureus.76007","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T14:52:08Z","timestamp":1734619928000},"source":"Crossref","is-referenced-by-count":6,"title":["Acute Pancreatitis Caused by Tirzepatide"],"prefix":"10.7759","author":[{"given":"Nur","family":"Mando","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Short","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Gillen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.14110","article-title":"The novel dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide transiently delays gastric emptying similarly to selective long-acting GLP-1 receptor agonists","volume":"22","author":"Urva S","year":"2020","unstructured":"Urva S, Coskun T, Loghin C, et al.. The novel dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide transiently delays gastric emptying similarly to selective long-acting GLP-1 receptor agonists. Diabetes Obes Metab. 2020, 22:1886-91. 10.1111\/dom.14110","journal-title":"Diabetes Obes Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0285197","article-title":"Weight loss efficiency and safety of tirzepatide: a systematic review","volume":"18","author":"Lin F","year":"2023","unstructured":"Lin F, Yu B, Ling B, et al.. Weight loss efficiency and safety of tirzepatide: a systematic review. PLoS One. 2023, 18:e0285197. 10.1371\/journal.pone.0285197","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.24945","article-title":"Continued treatment With tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial","volume":"331","author":"Aronne LJ","year":"2024","unstructured":"Aronne LJ, Sattar N, Horn DB, et al.. Continued treatment With tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial. JAMA. 2024, 331:38-48. 10.1001\/jama.2023.24945","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/obr.13543","article-title":"Comparative effectiveness of glucagon-like peptide-1 receptor agonists for the management of obesity in adults without diabetes: a network meta-analysis of randomized clinical trials","volume":"24","author":"Alkhezi OS","year":"2023","unstructured":"Alkhezi OS, Alahmed AA, Alfayez OM, Alzuman OA, Almutairi AR, Almohammed OA. Comparative effectiveness of glucagon-like peptide-1 receptor agonists for the management of obesity in adults without diabetes: a network meta-analysis of randomized clinical trials. Obes Rev. 2023, 24:e13543. 10.1111\/obr.13543","journal-title":"Obes Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-023-01451-z","article-title":"Patient-reported outcomes in people with type\u00a02 diabetes receiving tirzepatide in the SURPASS clinical trial programme","volume":"14","author":"Boye KS","year":"2023","unstructured":"Boye KS, Thieu VT, Sapin H, et al.. Patient-reported outcomes in people with type\u00a02 diabetes receiving tirzepatide in the SURPASS clinical trial programme. Diabetes Ther. 2023, 14:1833-52. 10.1007\/s13300-023-01451-z","journal-title":"Diabetes Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/bph.15647","article-title":"Glucagon-like peptide-1 in diabetes care: can glycaemic control be achieved without nausea and vomiting?","volume":"179","author":"Borner T","year":"2022","unstructured":"Borner T, Tinsley IC, Doyle RP, Hayes MR, De Jonghe BC. Glucagon-like peptide-1 in diabetes care: can glycaemic control be achieved without nausea and vomiting?. Br J Pharmacol. 2022, 179:542-56. 10.1111\/bph.15647","journal-title":"Br J Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvad016","article-title":"Adverse events related to tirzepatide","volume":"7","author":"Mishra R","year":"2023","unstructured":"Mishra R, Raj R, Elshimy G, et al.. Adverse events related to tirzepatide. J Endocr Soc. 2023, 7:bvad016. 10.1210\/jendso\/bvad016","journal-title":"J Endocr Soc"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1214334","article-title":"Safety issues of tirzepatide (pancreatitis and gallbladder or biliary disease) in type 2 diabetes and obesity: a systematic review and meta-analysis","volume":"14","author":"Zeng Q","year":"2023","unstructured":"Zeng Q, Xu J, Mu X, Shi Y, Fan H, Li S. Safety issues of tirzepatide (pancreatitis and gallbladder or biliary disease) in type 2 diabetes and obesity: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2023, 14:1214334. 10.3389\/fendo.2023.1214334","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12081974","article-title":"Diagnosis and treatment of acute pancreatitis","volume":"12","author":"Walkowska J","year":"2022","unstructured":"Walkowska J, Zielinska N, Tubbs RS, Podg\u00f3rski M, D\u0142ubek-Ruxer J, Olewnik \u0141. Diagnosis and treatment of acute pancreatitis. Diagnostics (Basel). 2022, 12:1974. 10.3390\/diagnostics12081974","journal-title":"Diagnostics (Basel)"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.14423\/SMJ.0000000000000727","article-title":"Acute pancreatitis: etiology, pathology, diagnosis, and treatment","volume":"110","author":"Majidi S","year":"2017","unstructured":"Majidi S, Golembioski A, Wilson SL, Thompson EC. Acute pancreatitis: etiology, pathology, diagnosis, and treatment. South Med J. 2017, 110:727-32. 10.14423\/SMJ.0000000000000727","journal-title":"South Med J"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60649-8","article-title":"Acute pancreatitis","volume":"386","author":"Lankisch PG","year":"2015","unstructured":"Lankisch PG, Apte M, Banks P. Acute pancreatitis. Lancet. 2015, 386:85-96. 10.1016\/S0140-6736(14)60649-8","journal-title":"Lancet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.2337\/cd19-0100","article-title":"Switching between glucagon-like peptide-1 receptor agonists: rationale and practical guidance","volume":"38","author":"Almandoz JP","year":"2020","unstructured":"Almandoz JP, Lingvay I, Morales J, Campos C. Switching between glucagon-like peptide-1 receptor agonists: rationale and practical guidance. Clin Diabetes. 2020, 38:390-402. 10.2337\/cd19-0100","journal-title":"Clin Diabetes"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/326365-acute-pancreatitis-caused-by-tirzepatide","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T14:52:09Z","timestamp":1734619929000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/326365-acute-pancreatitis-caused-by-tirzepatide"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,19]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.76007","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,19]]}}}